MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

$1.33
+0.02 (+1.53%)
As of Aug 15, 2:19 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,042.9% upside
Low Target $17.57
Average Target $28.50
High Target $41.49
Current Price $1.33
Current
$1.33
Target
$28.50
$17.57 $28.50 avg $41.49
Scenario Analysis
Bear Case
$17.57
1,221.1%
Low target
Base Case
$28.50
+2,042.9%
Avg target
Bull Case
$41.49
+3,019.5%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$1.96
-32.1% from high
52-Week Low
$1.17
+13.9% from low
Target vs 52W High
$28.50
+1,354.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%